On 9 January 2019 a Joint Meeting of the IDEA Supervisory Group (SG) and the IDEA Management Team took place in London.
On 9 January 2019 a Joint Meeting of the IDEA Supervisory Group (SG) and the IDEA Management Team took place in London.
The groups discussed a series of topics including the future of IDEA, QRA-2 SCCS Opinion follow-up, QRA-2 publication, clinical surveillance, pre- and prohaptens, and characterization and categorization in the context of animal alternatives.
Click the link below to read a summary report
